Genetic mutations and polymorphisms of axon guidance factors in the development of human retinopathy of prematurity
Genetic mutations and polymorphisms of axon guidance factors in the development of human retinopathy of prematurity
批准号:
23791223
负责人:
MIWA Akihiro
金额:
$2.0万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011 至 2012
中文摘要
在轴突导向因子中,我们以促红细胞生成素(EPO)为研究对象,探讨EPO基因启动子区rs1617640等位基因A频率与早产儿视网膜病变(ROP)发生的相关性。对44例ROP新生儿和62例妊娠32周前出生的非ROP新生儿进行了检查。A等位基因频率和基因型频率在各组间差异无统计学意义。Logistic多元回归分析显示,补充重组人EPO是ROP发生的危险因素。外源性EPO而非内源性EPO可能是ROP发生的危险因素。
英文摘要
Among axon guidance factors, we focused on erythropoietin (EPO), and investigated correlation between the development of retinopathy of prematurity (ROP) and allele A frequency of rs1617640, which was a single nucleotide polymorphism in the promoter area of EPOgene. Forty-four neonates with ROP and 62 non-ROP neonates born before 32 weeks of gestations were examined. There were no significant differences in allele A frequency and genotype frequency between the groups. A logisticmultiple regression analysis revealed that supplementation of human recombinant EPO was a risk factor for the development of ROP. Exogenous EPO, not endogenous EPO seems to be a risk factor for the development of ROP.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金